TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 1,81
arrow_upward
+1,69%(+0,030) 1D
US$ 1,81
0,00% (0,00)
bedtimeAfter-market
Fechado: 30 de abr., 16:00:00 GMT-4 · USD
search
Todos os símbolos
1D
5D
1M
6M
YTD
1A
5A
MÁX
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para TMCI…
Abrir
US$ 1,77
Alta
US$ 1,96
Baixa
US$ 1,72
Valor de mercado
117,26 mi
Volume médio
886,48 mil
Volume
2,00
Alto — 52 sem
US$ 7,78
Baixo — 52 sem
US$ 1,17
LPA
-US$ 0,93
Beta
0,88
Ações em circulação
64,78 mi
Nº de funcionários
450
Notícias
De fontes em toda a Web
MarketBeat
·
há 4 horas
Treace Medical Concepts (TMCI) to Release Earnings on Friday
Newser
·
há 1 semana
TMCI (Treace Medical Concepts Inc.) notches narrow Q4 2025 EPS beat, shares rise 3.74 percent on positive investor sentiment. - Weakness Phase
Perfil
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Sobre Treace Medical Concepts, Inc
O conteúdo gerado com IA pode ter erros. Saiba mais